Bicocca Open Archive

Logo unimib boa
PERSEGHIN, GIANLUCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.790
AS - Asia 12.672
EU - Europa 7.511
SA - Sud America 1.856
AF - Africa 327
OC - Oceania 57
Continente sconosciuto - Info sul continente non disponibili 16
Totale 37.229
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.418
SG - Singapore 4.826
CN - Cina 2.647
HK - Hong Kong 1.926
RU - Federazione Russa 1.502
IT - Italia 1.493
VN - Vietnam 1.399
BR - Brasile 1.388
IE - Irlanda 936
DE - Germania 899
SE - Svezia 815
GB - Regno Unito 438
FR - Francia 399
IN - India 389
UA - Ucraina 239
CA - Canada 228
BD - Bangladesh 213
ID - Indonesia 184
FI - Finlandia 177
AR - Argentina 173
IQ - Iraq 147
KR - Corea 143
TR - Turchia 141
AT - Austria 119
PK - Pakistan 112
NL - Olanda 104
ZA - Sudafrica 99
JP - Giappone 98
MX - Messico 85
EC - Ecuador 72
CO - Colombia 66
PH - Filippine 66
ES - Italia 65
SA - Arabia Saudita 65
PL - Polonia 63
CH - Svizzera 53
AU - Australia 51
DK - Danimarca 51
EG - Egitto 42
UZ - Uzbekistan 42
BE - Belgio 40
VE - Venezuela 40
MY - Malesia 39
CL - Cile 37
MA - Marocco 34
JO - Giordania 31
KE - Kenya 27
PY - Paraguay 25
IR - Iran 21
AE - Emirati Arabi Uniti 20
DZ - Algeria 20
TN - Tunisia 20
UY - Uruguay 20
PE - Perù 19
TH - Thailandia 19
TW - Taiwan 19
AZ - Azerbaigian 18
NP - Nepal 18
RO - Romania 18
PT - Portogallo 16
KZ - Kazakistan 15
PA - Panama 15
ET - Etiopia 14
OM - Oman 14
BG - Bulgaria 13
CZ - Repubblica Ceca 13
IL - Israele 12
LB - Libano 12
NG - Nigeria 12
BO - Bolivia 10
GR - Grecia 9
LT - Lituania 9
DO - Repubblica Dominicana 8
NI - Nicaragua 8
SN - Senegal 8
CI - Costa d'Avorio 7
EU - Europa 7
HN - Honduras 7
HR - Croazia 7
NZ - Nuova Zelanda 6
PS - Palestinian Territory 6
A2 - ???statistics.table.value.countryCode.A2??? 5
AO - Angola 5
BY - Bielorussia 5
CR - Costa Rica 5
GE - Georgia 4
GT - Guatemala 4
KG - Kirghizistan 4
LA - Repubblica Popolare Democratica del Laos 4
NO - Norvegia 4
RS - Serbia 4
ZM - Zambia 4
ZW - Zimbabwe 4
AL - Albania 3
BH - Bahrain 3
BW - Botswana 3
EE - Estonia 3
GY - Guiana 3
HU - Ungheria 3
JM - Giamaica 3
Totale 37.159
Salva come PNG Salva come JPEG
Città #
Singapore 2.658
Hong Kong 1.884
Ann Arbor 1.572
Ashburn 1.024
Chandler 997
San Jose 899
Dublin 880
Santa Clara 726
Fairfield 666
Frankfurt am Main 643
New York 555
Beijing 526
Chicago 474
Wilmington 423
Woodbridge 419
Princeton 392
Ho Chi Minh City 391
Dearborn 375
Milan 361
Houston 357
Hanoi 339
Jacksonville 322
The Dalles 298
Hefei 276
Los Angeles 264
Dallas 260
Seattle 233
Lauterbourg 227
Cambridge 216
Altamura 194
Lawrence 193
Hangzhou 182
Nanjing 156
Moscow 137
Jakarta 127
Helsinki 126
Seoul 119
São Paulo 116
San Diego 113
Buffalo 110
Council Bluffs 109
Shanghai 104
London 90
Vienna 87
Guangzhou 82
Toronto 80
Boardman 79
Andover 67
Munich 63
Rome 59
Tokyo 59
Baghdad 57
Orem 57
Salt Lake City 53
Shenyang 53
Da Nang 52
Haiphong 51
Rio de Janeiro 50
Zurich 48
Nanchang 45
Montreal 43
Dhaka 42
Dong Ket 42
Warsaw 42
Tashkent 37
Changsha 36
Johannesburg 36
Hebei 35
Bari 34
Brussels 34
Hải Dương 34
Nuremberg 34
Phoenix 34
Biên Hòa 33
Elk Grove Village 32
Lappeenranta 32
Mumbai 32
Riyadh 32
Atlanta 31
Falls Church 31
Lahore 31
Tianjin 31
Brasília 30
Norwalk 30
Istanbul 29
Stockholm 29
Chennai 28
Tampa 28
Amman 27
Brooklyn 27
San Francisco 27
Jiaxing 25
Jinan 25
New Delhi 25
Pune 25
Belo Horizonte 24
Denver 24
Guayaquil 24
Monza 24
Mountain View 24
Totale 22.818
Salva come PNG Salva come JPEG
Nome #
From NAFLD to MAFLD and MASLD: a tale of alcohol, stigma and metabolic dysfunction 591
NAFLD/NASH in patients with type 2 diabetes and related treatment options 568
Is Switching from Oral Antidiabetic Therapy to Insulin Associated with an Increased Fracture Risk? 448
Exploring the landscape of steatotic liver disease in the general US population 426
Metabolic dysfunction-associated steatotic liver disease, insulin sensitivity and continuous glucose monitoring metrics in patients with type 1 diabetes: A multi-centre cross-sectional study 388
Activation of angiotensin type 2 (AT2) receptors prevents myocardial hypertrophy in Zucker diabetic fatty rats 348
Endocrinology and Metabolic Diseases (Including Diabetes) 320
Fasting whole-body energy homeostasis and hepatic energy metabolism in nondiabetic humans with fatty liver 320
Adherence to clinical evaluations in women with pre-existing diabetes during pregnancy: A call to action from an Italian real-life investigation 273
Resting Energy Expenditure in Obese Women with Primary Hypothyroidism and Appropriate Levothyroxine Replacement Therapy 271
Malattie delle paratiroidi e del metabolismo fosfo-calcico - Ipoparatiroidismo 265
Renal Anti-Fibrotic Effect of Sodium Glucose Cotransporter 2 Inhibition in Angiotensin II-Dependent Hypertension 264
Italian Titration Approach Study (ITAS) with insulin glargine 300 U/mL in insulin-naïve type 2 diabetes: Design and population 249
Resting Whole Body Energy Metabolism in Class 3 Obesity; from Preserved Insulin Sensitivity to Overt Type 2 Diabetes 249
Cost-effectiveness of the adherence with recommendations for clinical monitoring of patients with diabetes 247
[OP.4B.05] MIR-30A-3P EXPRESSION IN THE HEARTS OF DIABETIC RATS 245
Sodium-glucose cotransporter 2 inhibition prevents renal fibrosis in cyclosporine nephropathy 232
Sympathetic neural abnormalities in type 1 and type 2 diabetes: a systematic review and meta-analysis 229
Comparing medication persistence with oral and subcutaneous semaglutide in a real-world setting 223
Advancements in pharmacological treatment of NAFLD/MASLD: a focus on metabolic and liver-targeted interventions 215
Anomalous leucine metabolism in total lipoatrophic diabetes: a possible mechanism of muscle mass hypertrophy 213
High Prevalence of Advanced Liver Fibrosis Assessed by Transient Elastography Among U.S. Adults With Type 2 Diabetes 211
Non-alcoholic fatty liver disease: A risk factor for myocardial dysfunction? 208
Increased mediastinal fat and impaired left ventricular energy metabolism in young men with newly found fatty liver 206
Compassionate use of Ruxolitinib in patients with SarsCov-2 infection not on mechanical ventilation. Short-term effects on inflammation and ventilation 206
Adherence to GLP1-RA and SGLT2-I affects clinical outcomes and costs in patients with type 2 diabetes 203
Brief report: Serum retinol-binding protein-4, leptin, and adiponectin concentrations are related to ectopic fat accumulation 203
Seasonal variation in estimated cardiovascular risk in patients with type 2 diabetes 202
Effect of L-Acetylcarnitine on body composition in HIV-related lipodystrophy 201
Impact of MASLD and MetALD on clinical outcomes: A meta-analysis of preliminary evidence 199
Habitual physical activity is associated with intrahepatic fat content in humans 199
The Role of Natriuretic Peptides in the Management of Heart Failure with a Focus on the Patient with Diabetes 192
Effect of the sporting discipline on the right and left ventricular morphology and function of elite male track runners: A magnetic resonance imaging and phosphorus 31 spectroscopy study 191
SGLT2 INHIBITION PREVENTS RENAL FIBROSIS IN CYCLOSPORINE NEPHROPATHY 191
Time trends in liver-related mortality in people with and without diabetes: Results from a population based study 190
Noninvasive identification of probable fibrotic nonalcoholic steatohepatitis across the spectrum of glucose tolerance in the United States 190
Short-term evaluation of cardiac morphology, function, metabolism and structure following diagnosis of adult-onset growth hormone deficiency 190
Hepatitis C virus infection and diabetes: a complex bidirectional relationship 190
Cardioprotective Effects of Sodium Glucose Cotransporter 2 Inhibition in Angiotensin II-Dependent Hypertension Are Mediated by the Local Reduction of Sympathetic Activity and Inflammation 189
Screening for non-alcoholic fatty liver disease in type 2 diabetes using non-invasive scores and association with diabetic complications 189
Prolonged Use of Proton Pump Inhibitors and Risk of Type 2 Diabetes: Results From a Large Population-Based Nested Case-Control Study 187
Impact of using different biomarkers of liver fibrosis on hepatologic referral of individuals with severe obesity and NAFLD 186
A multi-society Delphi consensus statement on new fatty liver disease nomenclature 185
Abnormal left ventricular energy metabolism in obese men with preserved systolic and diastolic functions is associated with insulin resistance 185
Adherence to antidiabetic drug therapy and reduction of fatal events in elderly frail patients 183
Changes in the Prescription of Glucose-Lowering Medications in Patients With Type 2 Diabetes Mellitus After a Cardiovascular Event: A Call to Action From the DATAFILE Study 183
The "Early Treatment" Approach Reducing Cardiovascular Risk in Patients with Type 2 Diabetes: A Consensus From an Expert Panel Using the Delphi Technique 182
Development of a new model of insulin sensitivity in patients with type 2 diabetes and association with mortality 181
Left ventricular function and energy metabolism in middle-aged men undergoing long-lasting sustained aerobic oxidative training 181
Lack of awareness of liver organ damage in patients with type 2 diabetes 181
A global action agenda for turning the tide on fatty liver disease 180
Open questions on basal insulin therapy in T2D: a Delphi consensus 179
Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes: Screening, Diagnosis, and Treatment 177
Implementing metabolic dysfunction-associated steatotic liver disease guidelines in patients with type 2 diabetes 177
Nonalcoholic Fatty Liver Disease, Liver Fibrosis and Cardiovascular Disease in the Adult US Population 176
Left ventricular function and energy homeostasis in patients with type 1 diabetes with and without microvascular complications 174
Impaired left ventricular energy metabolism in patients with hypertrophic cardiomyopathy is related to the extension of fibrosis at delayed gadolinium-enhanced magnetic resonance imaging 174
Setting up of a machine learning algorithm for the identification of severe liver fibrosis profile in the general US population cohort 173
Baseline TSH levels and short-term weight loss after different procedures of bariatric surgery 173
Myocardial metabolism studied during warm blood antero-retrograde reperfusion in ischaemic human hearts 173
Authors' response to Guo, Wei et al. 172
Insulin resistance and whole body energy homeostasis in obese adolescents with fatty liver disease 172
Liver fibrosis, NT-ProBNP and mortality in patients with MASLD: a population-based cohort study 171
A multi-society Delphi consensus statement on new fatty liver disease nomenclature 171
Metabolic and psychological features are associated with weight loss 12 months after sleeve gastrectomy 171
Beneficial effects of beta-blockers on left ventricular function and cellular energy reserve in patients with heart failure 170
Preferences, Expectations and Attitudes on Basal Insulin from Patient–Physician–Payer Perspective: A Multi-stakeholder Survey by the Italian Diabetes Society (ITA4P Study) 169
Effects of atazanavir/ritonavir and lopinavir/ritonavir on glucose uptake and insulin sensitivity [9] 169
Impaired net hepatic glycogen synthesis in insulin-dependent diabetic subjects during mixed meal ingestion: A 13C nuclear magnetic resonance spectroscopy study 169
Increased glucose transport-phosphorylation and muscle glycogen synthesis after exercise training in insulin-resistant subjects 168
Fertilizing a patient engagement ecosystem to innovate healthcare: Toward the first Italian Consensus conference on patient engagement 167
NT-ProBNP and mortality across the spectrum of glucose tolerance in the general US population 166
Authors' reply to Zou et al 166
Prevalence of Liver Steatosis and Fibrosis Detected by Transient Elastography in Adolescents in the 2017–2018 National Health and Nutrition Examination Survey 165
Differential Association of Sex Hormones with Metabolic Parameters and Body Composition in Men and Women from the United States 164
13C/31P NMR studies on the mechanism of insulin resistance in obesity 164
Mechanism of free fatty acid-induced insulin resistance in humans 163
Reduced intrahepatic fat content is associated with increased whole-body lipid oxidation in patients with type 1 diabetes 163
Renal protection: a leading mechanism for cardiovascular benefit in patients treated with SGLT2 inhibitors 163
NMR studies of muscle glycogen synthesis in insulin-resistant offspring of parents with non-insulin-dependent diabetes mellitus immediately after glycogen-depleting exercise 162
Elevated fasting plasma C-peptide occurs in non-diabetic individuals with fatty liver, irrespective of insulin resistance 162
Impact of diabetes on COVID-19-related in-hospital mortality: a retrospective study from Northern Italy 162
Comparing medication persistence among patients with type 2 diabetes using sodium-glucose cotransporter 2 inhibitors or glucagon-like peptide-1 receptor agonists in real-world setting 160
The roles of insulin and glucagon in the regulation of hepatic glycogen synthesis and turnover in humans 159
Pazienti diabetici di tipo 2, non in terapia insulinica e albumina glicata: UNA valutazione multidimensionale [Insuline-Naive type 2 diabetic patients: a multidimensional evaluation on the role of glycated albumin] 159
Impact of the duration of type 2 diabetes on the screening for nonal- coholic fatty liver disease and advanced fibrosis 159
Blood pressure, glycemic status and advanced liver fibrosis assessed by transient elastography in the general United States population 159
Nonalcoholic Fatty Liver Disease and Advanced Fibrosis in US Adults Across Blood Pressure Categories 158
Effect of pancreas transplantation on free fatty acid metabolism in uremic IDDM patients 157
An unexpected bilateral mass after total thyroidectomy 157
Collaborative synergy in the management of diabetic patients with recent acute coronary syndrome 156
Regulation of glucose homeostasis in humans with denervated livers 155
Sympathetic Neural Mechanisms Underlying Attended and Unattended Blood Pressure Measurement 155
Evaluating the Prognostic Value of the Triglyceride–Glucose Index in Different Populations: A Critical Analysis 154
NAIF: A novel artificial intelligence-based tool for accurate diagnosis of stage F3/F4 liver fibrosis in the general adult population, validated with three external datasets 154
A global research priority agenda to advance public health responses to fatty liver disease 154
Sodium Glucose Cotransporter-2 Inhibitors in Non-Diabetic Kidney Disease: Evidence in Experimental Models 153
Lack of feedback inhibition of insulin secretion in denervated human pancreas 153
Persistence of counter‐regulatory abnormalities in insulin‐dependent diabetes mellitus after pancreas transplantation 153
Effect of liver transplantation in cirrhotic diabetic patients 153
Totale 20.401
Salva come PNG Salva come JPEG
Categoria #
all - tutte 148.026
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 148.026
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021431 0 0 0 0 0 0 0 0 0 0 178 253
2021/20222.371 184 242 429 123 62 136 124 134 146 169 234 388
2022/20233.936 505 925 368 376 272 687 44 234 277 53 105 90
2023/20243.130 182 117 135 215 377 713 543 113 258 68 41 368
2024/20257.940 505 922 442 419 681 336 542 304 709 1.002 737 1.341
2025/202614.777 1.528 1.184 1.305 1.567 1.845 928 2.308 1.001 1.467 1.421 223 0
Totale 38.329